Related Experiment Video
Updated: Jul 18, 2026

Strategies for Tracking Anastasis, A Cell Survival Phenomenon that Reverses Apoptosis
Published on: February 16, 2015
Following the TRAIL to apoptosis
Bharti R Chaudhari1, Richard F Murphy, Devendra K Agrawal
1Department of Biomedical Sciences, Creighton University School of Medicine, Omaha, NE 68178, USA.
Abstract:
Apoptosis, programmed cell death, eliminates injured or harmful cells. It can mediate its response through the actions of death ligands including TRAIL. TRAIL, a member of TNF superfamily, induces apoptosis of transformed cells through the action of death domain receptors DR-4 and DR5. It directly induces apoptosis through an extrinsic pathway, which involves the activation of caspases. TRAIL also is able to prevent apoptosis through the actions of its decoy receptors DcR-1 and DcR-2. Various regulators of TRAIL include FADD, IAPs, Bcl-2s, p53, and FLIPs. TRAIL is present in cells involved in asthma including eosinophils, mast cells, fibroblasts, and airway epithelial cells. It is expressed in airway remodeling and may be linked with the pathways of transforming growth factor-beta1, which is thought to cause damage to the epithelium. The repair process of the epithelium is hindered as a result of increased apoptosis induced by TGF-beta1, which overlaps with the pathways of TRAIL. Analogs of TRAIL could have therapeutical applications for asthma. TRAIL is also seen as the basis for a "miracle" drug for cancer because of its ability to selectively kill cancer cells.
Insights
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) triggers programmed cell death in harmful cells, including cancer. TRAIL analogs show therapeutic potential for asthma and cancer treatment.
Area of Science:
- Cell Biology
- Immunology
- Molecular Biology
Background:
- Apoptosis, or programmed cell death, is crucial for eliminating damaged cells.
- TRAIL (Tumor necrosis factor-related apoptosis-inducing ligand), a TNF superfamily member, induces apoptosis via death receptors DR-4/DR-5 and extrinsic pathways.
- TRAIL's function is modulated by decoy receptors (DcR-1/DcR-2) and regulators like FADD, IAPs, Bcl-2s, p53, and FLIPs.
Purpose of the Study:
- To investigate the role of TRAIL in asthma pathogenesis.
- To explore the therapeutic potential of TRAIL analogs in asthma and cancer.
Main Methods:
- Analysis of TRAIL expression in asthma-related cells (eosinophils, mast cells, fibroblasts, airway epithelial cells).
- Examination of TRAIL's interaction with transforming growth factor-beta1 (TGF-beta1) pathways in airway remodeling.
- Review of TRAIL's mechanisms in selective cancer cell apoptosis.
Main Results:
- TRAIL is expressed in cells implicated in asthma and airway remodeling.
- TGF-beta1-induced apoptosis overlaps with TRAIL pathways, potentially hindering epithelial repair.
- TRAIL selectively induces apoptosis in cancer cells.
Conclusions:
- TRAIL plays a role in asthma pathophysiology and airway remodeling.
- TRAIL-based therapies, including analogs, hold promise for treating asthma and cancer due to selective cancer cell killing properties.
Related Concept Videos
Apoptosis
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...

